CRMD
CorMedix Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -11.1% ·
aandelenstroom +6.0% ·
netto nieuwe posities -12.5%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | +1 | 33.03K | $241,810 | +1 | n/a |
| Q2 2026 | 84 | +2 | 27.17M | $213.22M | +4 | −2 |
| Q1 2026 | 85 | -1 | 25.38M | $172.62M | +10 | −11 |
| Q4 2025 | 85 | +1 | 28.40M | $330.32M | +1 | n/a |
| Q3 2025 | 16 | -2 | 20.70M | $240.74M | +1 | −3 |
| Q2 2025 | 15 | +1 | 18.26M | $224.97M | +2 | −1 |
| Q1 2025 | 11 | 0 | 6.59M | $40.58M | +1 | −1 |
| Q4 2024 | 11 | +1 | 7.02M | $56.86M | +2 | −1 |
| Q3 2024 | 9 | -2 | 3.76M | $30.38M | n/a | −2 |
| Q2 2024 | 11 | n/a | 4.01M | $17.37M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 5.69M | +6.1% | $66.15M | 0.0% | ▲ Add | 2 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (passief) | 3.98M | -8.0% | $46.26M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Marshall Wace ✦ | 3.47M | +34.6% | $40.40M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 4 | State Street Global Advisors ✦ (passief) | 1.84M | +14.6% | $21.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 1.81M | +13.4% | $21.05M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 1.72M | +0.2% | $19.97M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 843.57K | n/a | $9.81M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 8 | Millennium Management ✦ | 395.45K | +602.6% | $4.60M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Wellington Management ✦ | 250.37K | +46.3% | $2.91M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 10 | Goldman Sachs Group ✦ | 230.81K | n/a | $2.68M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | JPMorgan Chase ✦ | 194.46K | n/a | $2.26M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 12 | Two Sigma Investments ✦ | 128.56K | -59.4% | $1.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 75.69K | -23.3% | $880,298 | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 14 | T. Rowe Price ✦ | 39.27K | +22.3% | $457,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 31.36K | Nieuw | $364,775 | 0.0% | New | 1 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 8.38K | +7.8% | $97,503 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Gotham Asset Management | $364,775 | 0.0% |
Verlaten
| D. E. Shaw & Co. | $2.71M | was 0.0% |
| Renaissance Technologies | $1.88M | was 0.0% |
| Point72 Asset Management | $345,443 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 184 houders, 40.43M aandelen, $271.85M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.